Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review

Supportive Care in Cancer

Volumn 24, Issue 1, 2016, Pages 481-497

  Henneghan, Ashley ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Breast cancer; Cognition; Mixed method systematic review; Modifiable factors; Survivors

Indexed keywords

AFFECT; BREAST CANCER; CANCER SURVIVOR; CANCER THERAPY; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; HUMAN; LIFESTYLE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; REVIEW; RISK FACTOR; SLEEP QUALITY; SOCIAL PSYCHOLOGY; STRESS MANAGEMENT; SURVIVOR; SYSTEMATIC REVIEW; ADULT; AGED; BREAST TUMOR; COGNITION DISORDERS; FEMALE; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGY; SLEEP WAKE DISORDERS;

ADULT; AGED; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; RISK FACTORS; SLEEP WAKE DISORDERS; STRESS, PSYCHOLOGICAL; SURVIVORS;

EID: 84949106918     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2927-y     Document Type: Review

References (79)

1. American Cancer Society (2013) Breast cancer facts & figures 2013–2014. American Cancer Society, Atlanta
2. Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26(1):102–113. doi:10.3109/09540261.2013.864260
3. Wefel JS, Schagen SB (2012) Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 12(3):267–275. doi:10.1007/s11910-012-0264-9
4. Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. J Cancer Surviv 3(4):223–232. doi:10.1007/s11764-009-0098-x
5. Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DH, Geist C et al (2013) Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun 30(Suppl):S99–S108. doi:10.1016/j.bbi.2012.07.015
6. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA (2004) ‘Chemobrain’ in breast carcinoma?: a prologue. Cancer 101(3):466–475. doi:10.1002/cncr.20393
7. Reid-Arndt SA (2009) Breast cancer and “chemobrain”: the consequences of cognitive difficulties following chemotherapy and the potential for recovery. Mo Med 106(2):127–131
8. Ottati A, Feuerstein M (2013) Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv 7(2):262–273. doi:10.1007/s11764-013-0275-9
9. Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH et al (2012) Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 30(29):3578–3587. doi:10.1200/jco.2011.39.5640
10. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104(10):2222–2233. doi:10.1002/cncr.21469
11. Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T (2013) A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 39(3):297–304. doi:10.1016/j.ctrv.2012.11.001
12. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 38(7):926–934. doi:10.1016/j.ctrv.2012.05.002
13. McDonald BC et al (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30(20):2500–2508
14. Kesler SR (2014) Default mode network as a potential biomarker of chemotherapy-related brain injury. Neurobiol Aging 35(Suppl 2):S11–S19
15. de Ruiter MB, Schagen SB (2013) Functional MRI studies in non-CNS cancers. Brain Imaging Behav 7(4):388–408
16. Holohan KN, Von Ah D, McDonald BC, Saykin AJ (2013) Neuroimaging, cancer, and cognition: state of the knowledge. Semin Oncol Nurs 29(4):280–287. doi:10.1016/j.soncn.2013.08.008
17. Saykin AJ, de Ruiter MB, McDonald BC, Deprez S, Silverman DH (2013) Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research. Brain Imaging Behav 7(4):363–373. doi:10.1007/s11682-013-9283-7
18. Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7(3):192–201
19. Vardy J (2009) Cognitive function in breast cancer survivors. Cancer Treat Res 151:387–419
20. Janelsins MC et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38(3):431–438
21. Ahles TA, Root JC, Ryan EL (2012) Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 30(30):3675–3686. doi:10.1200/jco.2012.43.0116
22. Arndt J, Das E, Schagen SB, Reid-Arndt SA, Cameron LD, Ahles TA (2013) Broadening the cancer and cognition landscape: the role of self-regulatory challenges. Psychooncology. doi:10.1002/pon.3351
23. Mandelblatt JS, Stern RA, Luta G, McGuckin M, Clapp JD, Hurria A et al (2014) Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol 32(18):1909–1918. doi:10.1200/JCO.2013.54.2050
24. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS et al (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28(29):4434–4440. doi:10.1200/jco.2009.27.0827
25. Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B et al (2003) The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12(6):612–619. doi:10.1002/pon.742
26. Andreano JM, Waisman J, Donley L, Cahill L (2012) Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress. Psychooncology 21(10):1091–1098. doi:10.1002/pon.2006
27. Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L (2004) What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 5(5):273–282. doi:10.1016/S1470-2045(04)01465-2
28. Wefel JS, Witgert ME, Meyers CA (2008) Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18(2):121–131. doi:10.1007/s11065-008-9058-x
29. Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98(23):1742–1745. doi:10.1093/jnci/djj470
30. Schilder CM, Seynaeve C, Linn SC, Boogerd W, Beex LV, Gundy CM et al (2010) Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit Rev Oncol Hematol 76(2):133–141. doi:10.1016/j.critrevonc.2009.11.001
31. Poppelreuter M, Weis J, Kulz AK, Tucha O, Lange KW, Bartsch HH (2004) Cognitive dysfunction and subjective complaints of cancer patients. A cross-sectional study in a cancer rehabilitation centre. Eur J Cancer 40(1):43–49
32. Pullens MJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psychooncology 19(11):1127–1138. doi:10.1002/pon.1673
33. Asher A (2011) Cognitive dysfunction among cancer survivors. Am J Phys Med Rehabil 90(5 Suppl 1):S16–S26. doi:10.1097/PHM.0b013e31820be463
34. Bower JE, Lamkin DM (2013) Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun 30(Suppl):S48–S57. doi:10.1016/j.bbi.2012.06.011
35. Cheung YT, Lim SR, Ho HK, Chan A (2013) Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS One 8(12), e81234. doi:10.1371/journal.pone.0081234
36. Kang DH, Rice M, Park NJ, Turner-Henson A, Downs C (2010) Stress and inflammation: a biobehavioral approach for nursing research. West J Nurs Res 32(6):730–760. doi:10.1177/0193945909356556
37. Pluye P, Gagnon MP, Griffiths F, Johnson-Lafleur J (2009) A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in Mixed Studies Reviews. Int J Nurs Stud 46(4):529–546. doi:10.1016/j.ijnurstu.2009.01.009
38. Donovan LA, Wakefield CE, Russell V, Cohn RJ (2015) Hospital-based bereavement services following the death of a child: a mixed study review. Palliat Med 29(3):193–210. doi:10.1177/0269216314556851
39. Khanassov V, Vedel I, Pluye P (2014) Barriers to implementation of case management for patients with dementia: a systematic mixed studies review. Ann Fam Med 12(5):456–465. doi:10.1370/afm.1677
40. Whittemore R, Jaser S, Chao A, Jang M, Grey M (2012) Psychological experience of parents of children with type 1 diabetes: a systematic mixed-studies review. Diabetes Educ 38(4):562–579. doi:10.1177/0145721712445216
41. Cheung YT et al (2015) Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study dagger. Ann Oncol. doi:10.1093/annonc/mdv206
42. Conroy SK et al (2013) Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat 137(2):493–502
43. Crowgey T, Peters KB, Hornsby WE, Lane A, McSherry F, Herndon JE 2nd et al (2014) Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study. Appl Physiol Nutr Metab 39(6):724–729. doi:10.1139/apnm-2013-0380
44. Pomykala KL, Ganz PA, Bower JE, Kwan L, Castellon SA, Mallam S et al (2013) The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav 7(4):511–523. doi:10.1007/s11682-013-9243-2
45. Chen ML, Miaskowski C, Liu LN, Chen SC (2012) Changes in perceived attentional function in women following breast cancer surgery. Breast Cancer Res Treat 131(2):599–606. doi:10.1007/s10549-011-1760-3
46. Jaremka LM, Peng J, Bornstein R, Alfano CM, Andridge RR, Povoski SP et al (2014) Cognitive problems among breast cancer survivors: loneliness enhances risk. Psychooncology. doi:10.1002/pon.3544
47. Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G et al (2013) Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun 30 Suppl:S109–S116. doi:10.1016/j.bbi.2012.05.017
48. Kesler SR et al (2013) Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging Behav 7(4):501–510
49. Sanford SD, Beaumont JL, Butt Z, Sweet JJ, Cella D, Wagner LI (2014) Prospective longitudinal evaluation of a symptom cluster in breast cancer. Pain Symptom Manage 47(4):721–730. doi:10.1016/j.jpainsymman.2013.05.010
50. Vearncombe KJ et al (2009) Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15(6):951–962
51. Cheung YT, Shwe M, Chui WK, Chay WY, Ang SF, Dent RA et al (2012) Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. Ann Pharmacother 46(12):1645–1655. doi:10.1345/aph.1R408
52. Myers JS, Wick JA, Klemp J (2015) Potential factors associated with perceived cognitive impairment in breast cancer survivors. Support Care Cancer. doi:10.1007/s00520-015-2708-7
53. Li J et al (2015) Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue. Psycho-Oncology 24(6):676–682
54. Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK et al (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20(4):831–839. doi:10.1007/s00520-011-1158-0
55. Mehlsen M et al (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18(3):248–257
56. Alvarez J, Meyer FL, Granoff DL, Lundy A (2013) The effect of EEG biofeedback on reducing postcancer cognitive impairment. Integr Cancer Ther 12(6):475–487. doi:10.1177/1534735413477192
57. Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M et al (2010) Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 19(12):1321–1328. doi:10.1002/pon.1695
58. Phillips KA, Ribi K, Sun Z, Stephens A, Thompson A, Harvey V et al (2010) Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast 19(5):388–395. doi:10.1016/j.breast.2010.03.025
59. Schagen SB, Das E, van Dam FS (2009) The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psycho-Oncology 18(6):674–678. doi:10.1002/pon.1454
60. Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39(1):E31–E40. doi:10.1188/12.onf.e31-e40
61. Cheung YT et al (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol 23(10):2547–2552
62. Player L, Mackenzie L, Willis K, Loh SY (2014) Women’s experiences of cognitive changes or ‘chemobrain’ following treatment for breast cancer: a role for occupational therapy? Aust Occup Ther J. doi:10.1111/1440-1630.12113
63. Munir F, Kalawsky K, Lawrence C, Yarker J, Haslam C, Ahmed S (2011) Cognitive intervention for breast cancer patients undergoing adjuvant chemotherapy: a needs analysis. Cancer Nurs 34(5):385–392. doi:10.1097/NCC.0b013e31820254f3
64. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26(6):971–982. doi:10.1200/JCO.2007.10.7805
65. Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8(11):887–899. doi:10.1038/nrc2507
66. Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ et al (2014) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology. doi:10.1002/pon.3545
67. Cheung YT, Chan A, Ng T et al (2014) The Association of Pro-inflammatory biomarkers and cognitive impairment in Asian breast cancer patients: a multi-centered, prospective, cohort study. International Cognition and Cancer Taskforce, Seattle
68. Bherer L, Erickson KI, Liu-Ambrose T (2013) A review of the effects of physical activity and exercise on cognitive and brain functions in older adults. J Aging Res. doi:10.1155/2013/657508
69. Aggarwal NT, Wilson RS, Beck TL, Rajan KB, Mendes de Leon CF, Evans DA et al (2014) Perceived stress and change in cognitive function among adults 65 years and older. Psychosom Med 76(1):80–85. doi:10.1097/PSY.0000000000000016
70. Reid-Arndt SA, Cox CR (2012) Stress, coping and cognitive deficits in women after surgery for breast cancer. J Clin Psychol Med Settings 19(2):127–137. doi:10.1007/s10880-011-9274-z
71. Kremen WS, Lachman ME, Pruessner JC, Sliwinski M, Wilson R (2012) Mechanisms of age-related cognitive change and targets for intervention: social interactions and stress. J Gerontol A Biol Sci Med Sci 67(7):760–765. doi:10.1093/gerona/gls125
72. Cacioppo JT, Hawkley LC (2009) Perceived social isolation and cognition. Trends Cogn Sci 13(10):447–454. doi:10.1016/j.tics.2009.06.005
73. Nelson WL, Suls J (2013) New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. J Pain Symptom Manage. doi:10.1016/j.jpainsymman.2012
74. Demark-Wahnefried W, Jones LW (2008) Promoting a healthy lifestyle among cancer survivors. Hematol Oncol Clin North Am 22(2):319–342
75. Hewitt M, Greenfield S, Stovall E (2005) (ed) From cancer patient to cancer survivor: lost in transition. The National Academies Press
76. Pekmezi DW, Demark-Wahnefried W (2011) Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol 50(2):167–178
77. Parelkar P, Thompson NJ, Kaw CK, Miner KR, Stein KD (2013) Stress coping and changes in health behavior among cancer survivors: a report from the American Cancer Society’s Study of Cancer Survivors-II (SCS-II). J Psychosoc Oncol 31(2):136–152. doi:10.1080/07347332.2012.761322
78. Blanchard CM, Courneya KS, Stein K (2008) Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol 26(13):2198–2204. doi:10.1200/JCO.2007.14.6217
79. Garland SN et al (2014) Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat 10:1113–1124